Thus, the GRP70-NF-κB-FAT10 axis could be a therapeutic target to treat hepatocellular carcinoma (HCC), and further proliferation of HCC cells could be inhibited or reduced [32]. Here, NFKB1 is linked to hepatocellular carcinoma.